Global Advanced Dermatology Drug Delivery Devices Market

F u-=
Global Advanced
Dermatology Drug
Delivery Devices Market
Focus on Product Type, Volume Sold,
Analysis and Forecast 2021-2030
August 2021
Table of Content
Global Advanced Dermatology Drug Delivery Devices Market
BIS Research is a leading market intelligence and technology research company. BIS Research
publishes in-depth market intelligence reports focusing on the market estimations, technology
analysis, emerging high-growth applications, deeply segmented granular country-level market data,
and other important market parameters useful in the strategic decision making for senior
management. BIS Research provides multi-client reports, company profiles, databases, and custom
research services.
Copyright © 2021 BIS Research

All Rights Reserved. This document contains highly confidential information and is the sole property
of BIS Research. Disclosing, copying, circulating, quoting, or otherwise reproducing any or all
contents of this document is strictly prohibited. Access to this information is provided exclusively for
the benefit of the people or organization concerned. It may not be accessed by or offered whether for
sale or otherwise to any third party.
All rights reserved at BIS Research 2

Table of Contents
Executive Summary……………………………………………………………...………….….27
1. Product Definition ..............................................................................................36
2. Scope of Research .............................................................................................37

2.1 Scope of Study ............................................................................................. 37
2.2 Inclusion and Exclusion Criteria ................................................................. 39
2.3 Key Questions Answered in the Report ..................................................... 40
3. Research Methodology ......................................................................................41

3.1 Data Collection and Analysis ...................................................................... 41
3.2 Data Sources ................................................................................................ 42
3.2.1 Primary Data Sources ....................................................................... 42
3.2.2 Secondary Data Sources .................................................................. 43
3.3 Data Triangulation ........................................................................................ 44
3.4 Market Estimation ........................................................................................ 45
3.5 Forecast Period Selection Criteria .............................................................. 47
3.6 Assumptions and Limitations ..................................................................... 47
4. Industry Analysis................................................................................................48
4.1 Technology Landscape ............................................................................... 48
4.1.1 Key Trends ......................................................................................... 49
4.1.1.1 Short-Term Potential (2-4 Years) ..................................................... 50
4.1.1.2 Mid-Term Potential (5-10 Years) ...................................................... 52
4.1.1.3 Long-Term Impact (8-12 Years) ....................................................... 53
4.2 Supply Chain Analysis................................................................................. 54
4.3 Funding Scenario ......................................................................................... 57
4.4 Regulatory Framework and Government Initiatives ................................. 60
4.4.1 Regulations in North America .......................................................... 60
4.4.1.1 U.S. .................................................................................................. 60
4.4.1.2 Canada ............................................................................................ 61
4.4.2 Regulations in Europe ...................................................................... 62

4.4.3 Regulations in Asia-Pacific .............................................................. 63

4.4.3.1 Japan ............................................................................................... 63
4.4.3.2 China ............................................................................................... 64
4.5 Patent Analysis ............................................................................................ 64
4.5.1 Patent Filing Trend (by Country) ...................................................... 64
4.5.2 Patent Filing Trend (by Year) ............................................................ 65
5. Impact of COVID-19 on Global Advanced Dermatology Drug Delivery

Devices Market ...................................................................................................67
5.1 Impact on Dermatology Practices .............................................................. 67
5.2 Impact on the Adoption of Advanced Dermatology Drug Delivery
Devices.......................................................................................................... 67
5.3 Impact on Market Size.................................................................................. 70
5.4 Impact of COVID-19 on Global Advanced Dermatology Drug
Delivery Devices Market .............................................................................. 71
5.4.1 Short-Term Impact (2-4 Years) ......................................................... 71
5.4.2 Mid-Term Impact (5-10 Years) .......................................................... 71
5.4.3 Long-Term Impact (8-12 Years) ........................................................ 72
5.5 Entry Barriers and Opportunities ............................................................... 72
6. Competitive Landscape .....................................................................................74

6.1 Market Share Analysis ................................................................................. 74
6.2 Key Strategies and Developments ............................................................. 75
6.2.1 Funding Activities ............................................................................. 77
6.2.2 Mergers and Acquisitions (M&A) ..................................................... 78
6.2.3 Partnerships, Alliances, and Business Expansions....................... 79
6.2.4 Regulatory and Legal Activities ....................................................... 80
6.2.5 New Offerings .................................................................................... 81
6.3 Business Model Analysis ............................................................................ 82
6.4 Pricing Analysis ........................................................................................... 84
7. Global Advanced Dermatology Drug Delivery Devices Market Scenario ......85

7.1 Assumptions and Limitations ..................................................................... 85
7.2 Key Findings and Opportunity Assessment .............................................. 86

7.3 Global Advanced Dermatology Drug Delivery Devices Market Size

and Forecast ................................................................................................. 88
7.3.1 Realistic Growth Scenario ................................................................ 88
7.3.2 Pessimistic/Conservative Growth Scenario .................................... 89
7.3.3 Optimistic Growth Scenario ............................................................. 90
7.4 Market Dynamics .......................................................................................... 91
7.4.1 Impact Analysis ................................................................................. 91
7.4.2 Market Growth Promoting Factors................................................... 92
7.4.2.1 Global Preference for Connected Devices ....................................... 92
7.4.2.2 Increasing Number of Business Synergies with Pharmaceutical
Companies ....................................................................................... 94
7.4.2.3 Novel Technologies in Drug Delivery ............................................... 95
7.4.2.4 Growing Focus on Prescription Adherence ...................................... 96
7.4.3 Market Growth Restraining Factors ................................................. 97
7.4.3.1 Stringent Regulations and Concerns Around Data Privacy.............. 97
7.4.3.2 Lack of Awareness Among a Large Section of the Population
in Emerging Countries ..................................................................... 98
7.4.4 Market Growth Opportunities ........................................................... 98
7.4.4.1 Development of a Customized Apps Marketplace for Pharma
Companies ....................................................................................... 98
7.4.4.2 Leveraging Synergies to Expand into Emerging Markets ................ 99
7.4.4.3 Developing Low-Cost Devices to Improve Sales in Price-
Sensitive Markets............................................................................. 99
8. Global Advanced Dermatology Drug Delivery Devices Market (by

Product Type) ...................................................................................................101
8.1 Opportunity Assessment........................................................................... 101
8.2 Growth Share Matrix .................................................................................. 101
8.3 Hardware ..................................................................................................... 103
8.3.1 Injectors ........................................................................................... 104
8.3.1.1 Key Players Competitive Benchmarking ........................................ 104
8.3.1.2 Market Dynamics ........................................................................... 105
8.3.1.3 Key Product Specifications ............................................................ 106
8.3.1.4 Unit Volume Sold ........................................................................... 108

8.3.1.4.1 Key Players ......................................................................... 109

8.3.1.4.2 End Market (OTC and Pharma) ........................................... 109
8.3.1.5 Market Size and Forecast .............................................................. 110
8.3.1.5.1 Disposable Injectors ............................................................ 111
8.3.1.5.2 Reusable Injectors ............................................................... 112
8.3.1.5.3 Wearable Injectors .............................................................. 113
8.3.2 Patches............................................................................................. 114
8.3.2.2 Market Dynamics ........................................................................... 115
8.3.2.4 Unit Volume Sold ........................................................................... 118
8.3.2.4.1 Key Players ......................................................................... 118
8.3.2.5.1 Microneedle Patches (MNPs) .............................................. 121
8.3.2.5.1.1 Solid Removable Microneedles .............................................123
8.3.2.5.1.2 Coated Microneedles .............................................................124
8.3.2.5.1.3 Dissolving Microneedles ........................................................125
8.3.2.5.1.4 Hollow Microneedles ..............................................................126
8.3.2.5.1.5 Hydrogel Forming Microneedles ............................................127
8.3.2.5.2 Needle-Less Patches .......................................................... 128
8.3.3 Airless Dispensers and Bottles ...................................................... 129
8.3.3.2 Market Dynamics ........................................................................... 130
8.3.3.4 Unit Volume Sold ........................................................................... 132
8.3.3.4.1 Key Players ......................................................................... 133
8.3.4 Dermal Pumps ................................................................................. 135
8.3.4.2 Market Dynamics ........................................................................... 136


8.3.4.4 Unit Volume Sold ........................................................................... 138
8.3.4.4.1 Key Players ......................................................................... 139
8.3.5 Valves ............................................................................................... 142
8.3.5.2 Market Dynamics ........................................................................... 143
8.3.5.4 Unit Volume Sold ........................................................................... 145
8.3.5.4.1 Key Players ......................................................................... 145
8.3.6 Other Devices .................................................................................. 147
8.3.6.2 Market Dynamics ........................................................................... 149
8.3.6.4 Unit Volume Sold ........................................................................... 151
8.3.6.4.1 Key Players ......................................................................... 151
8.3.7 Packaging Products ........................................................................ 153
8.3.7.1 Market Dynamics ........................................................................... 153
8.4 Software and Apps ..................................................................................... 156
9. Global Advanced Dermatology Drug Delivery Devices Market (by Sales

Channel) ............................................................................................................157
9.2 B2B Sales Channel .................................................................................... 158
9.3 B2C Sales Channel .................................................................................... 159

10. Global Advanced Dermatology Drug Delivery Devices Market (by

End User) ..........................................................................................................161
10.2 Hospitals ..................................................................................................... 162
10.3 Dermatology Practices .............................................................................. 163
10.4 Home Use.................................................................................................... 164
11. Global Advanced Dermatology Drug Delivery Devices Market

(by Region) ........................................................................................................166
11.1 Overview ..................................................................................................... 166
11.2 North America Advanced Dermatology Drug Delivery Devices
Market ......................................................................................................... 167
11.2.1 Key Findings and Opportunity Assessment ................................. 167
11.2.2 Market Dynamics Impact Analysis ................................................. 168
11.2.3 Market Size and Forecast ............................................................... 169
11.2.4 North America Advanced Dermatology Drug Delivery
Devices Market (by Product Type) ................................................. 170
Devices Market (by End User) ........................................................ 171
Devices Market (by Country) .......................................................... 172
11.2.6.1 U.S. ................................................................................................ 172
11.2.6.2 Canada .......................................................................................... 173
11.3 Europe Advanced Dermatology Drug Delivery Devices Market ............. 174
11.3.2 Market Dynamics: Impact Analysis................................................ 175
11.3.4 Europe Advanced Dermatology Drug Delivery Devices
Market (by Product Type) ............................................................... 178
Market (by End User)....................................................................... 179
Market (by Country)......................................................................... 180
11.3.6.1 Germany ........................................................................................ 180

11.3.6.2 U.K. ................................................................................................ 181

11.3.6.3 France............................................................................................ 182
11.3.6.4 Italy ................................................................................................ 183
11.3.6.5 Spain.............................................................................................. 184
11.3.6.6 Nordic Countries ............................................................................ 185
11.3.6.7 Rest-of-Europe .............................................................................. 186
11.4 Asia-Pacific Advanced Dermatology Drug Delivery Devices Market ..... 187
11.4.4 Asia-Pacific Advanced Dermatology Drug Delivery Devices
Market (by Product Type) ............................................................... 190
Market (by End User)....................................................................... 191
Market (by Country)......................................................................... 192
11.4.6.1 Japan ............................................................................................. 192
11.4.6.2 China ............................................................................................. 193
11.4.6.3 South Korea ................................................................................... 194
11.4.6.4 Australia and New Zealand ............................................................ 195
11.4.6.5 India ............................................................................................... 196
11.4.6.6 Rest-of-Asia-Pacific ....................................................................... 197
11.5 Latin America Advanced Dermatology Drug Delivery Devices
Market ......................................................................................................... 199
11.5.2 Market Dynamics Impact Analysis ................................................. 200
11.5.4 Latin America Advanced Dermatology Drug Delivery
Devices Market (by Country) .......................................................... 204
11.5.6.1 Brazil .............................................................................................. 204

11.5.6.2 Mexico ........................................................................................... 205

11.5.6.3 Argentina ....................................................................................... 206
11.5.6.4 Rest-of-Latin America .................................................................... 207
11.6 Rest-of-the-World Advanced Dermatology Drug Delivery Devices
Market ......................................................................................................... 208
11.6.4 Rest-of-the-World Advanced Dermatology Drug Delivery
11.6.5 Rest-of-the-World Advanced Dermatology Drug Delivery
12. Company Profiles .............................................................................................213

12.1 AptarGroup, Inc. ......................................................................................... 213
12.1.1 Company Overview ......................................................................... 213
12.1.2 Role of AptarGroup, Inc. in the Global Advanced
Dermatology Drug Delivery Devices Market ................................. 213
12.1.3 Product Portfolio ............................................................................. 214
12.1.3.1 Volume of Bottles Sold................................................................... 215
12.1.3.1.1 Less than 50 ml ................................................................... 215
12.1.3.1.2 50ml-100ml.......................................................................... 215
12.1.3.1.3 100ml-150ml........................................................................ 215
12.1.3.1.4 More than 150ml ................................................................. 216
12.1.4 Financials ......................................................................................... 216
12.1.5 Research and Development (R&D) Insights .................................. 218
12.1.6 Recent Developments ..................................................................... 218
12.1.7 SWOT Analysis ................................................................................ 219
12.2 Becton, Dickinson and Company ............................................................. 220
12.2.2 Role of Becton, Dickinson and Company in the Global
Advanced Dermatology Drug Delivery Devices Market ............... 220
12.2.3 Financials ......................................................................................... 221

12.2.5 SWOT Analysis ................................................................................ 224

12.3 Bespak ........................................................................................................ 225
12.3.2 Role of Bespak in the Global Advanced Dermatology Drug
Delivery Devices Market ................................................................. 225
12.3.4 SWOT Analysis ................................................................................ 227
12.4 Credence MedSystems, Inc. ...................................................................... 228
12.4.2 Role of Credence MedSystems, Inc. in the Global Advanced
12.4.4 SWOT Analysis ................................................................................ 230
12.5 E3D Elcam Drug Delivery Devices ............................................................ 231
12.5.2 Role of E3D Elcam Drug Delivery Devices in the Global
12.5.4 SWOT Analysis ................................................................................ 233
12.6 Kindeva Drug Delivery L.P. ....................................................................... 234
12.6.2 Role of Kindeva Drug Delivery L.P. in the Global Advanced
12.6.3 SWOT Analysis ................................................................................ 235
12.7 Latch Medical ............................................................................................. 236
12.7.2 Role of Latch Medical in the Global Advanced Dermatology
Drug Delivery Devices Market ........................................................ 236
12.7.4 SWOT Analysis ................................................................................ 237
12.8 LTS Lohmann Therapie-Systeme AG ....................................................... 238

12.8.2 Role of LTS Lohmann Therapie-Systeme AG in the Global

12.8.4 SWOT Analysis ................................................................................ 240
12.9 Medicsensors S.L ....................................................................................... 241
12.9.2 Role of Medicsensors S.L in the Global Advanced
12.9.3 SWOT Analysis ................................................................................ 242
12.10 Midas Pharma GmbH ................................................................................. 243
12.10.2 Role of Midas Pharma GmbH in the Global Advanced
12.10.4 SWOT Analysis ................................................................................ 245
12.11 Nemera ........................................................................................................ 246
12.11.2 Role of Nemera in the Global Advanced Dermatology Drug
Delivery Devices Market ................................................................. 246
12.11.4 SWOT Analysis ................................................................................ 248
12.12 Owen Mumford ........................................................................................... 249
12.12.2 Role of Owen Mumford in the Global Advanced Dermatology
12.12.4 SWOT Analysis ................................................................................ 251
12.13 Portal Instruments, Inc. ............................................................................. 252
12.13.2 Role of Portal Instruments, Inc. in the Global Advanced
12.13.4 SWOT Analysis ................................................................................ 254

12.14 Vaxxas Inc................................................................................................... 255

12.14.2 Role of Vaxxas Inc. in the Global Advanced Dermatology
12.14.4 SWOT Analysis ................................................................................ 257
12.15 West Pharmaceutical Services, Inc. ......................................................... 258
12.15.2 Role of West Pharmaceutical Services, Inc. in the Global
12.15.3 Financials ......................................................................................... 260
12.15.5 SWOT Analysis ................................................................................ 263

List of Tables
Table 1: Key Barriers and Possible Solutions to Entering the Global Advanced Dermatology
Drug Delivery Devices Market ................................................................................................ 28
Table 2: Global Advanced Dermatology Drug Delivery Devices Market Quarterly Key
Developments Analysis, January 2017-June 2021 ............................................................... 31
Table 3: Global Advanced Dermatology Drug Delivery Devices Market COVID-19 Recovery
Scenario Impact ...................................................................................................................... 34
Table 4.1: Global Advanced Dermatology Drug Delivery Devices Market Technology
Landscape ............................................................................................................................... 48
Table 4.2: Global Advanced Dermatology Drug Delivery Devices Market Funding, January
2017-January 2021 ................................................................................................................. 58
Table 4.3: European Commission Medical Device Directives ........................................................... 62
Table 5.1: Key Barriers and Possible Solutions in Entering into the Global Advanced
Dermatology Drug Delivery Devices Market .......................................................................... 72
Table 6.1: Global Advanced Dermatology Drug Delivery Devices Market Business Models .......... 83
Table 6.2: Global Advanced Dermatology Drug Delivery Devices Market Pricing Analysis (by
Product Type) .......................................................................................................................... 84
Table 7.1: Advanced Dermatology Drug Delivery Devices, Key Technologies ................................ 95
Table 8.1: Market Dynamics (Injectors) ............................................................................................ 105
Table 8.2: Key Product Specifications (Injectors)............................................................................. 106
Table 8.3: Unit Volume Sold (Injectors) – Key Players .................................................................... 109
Table 8.4: Market Dynamics (Patches) ............................................................................................ 116
Table 8.5: Key Product Specifications (Patches) ............................................................................. 117
Table 8.6: Unit Volume Sold (Patches) – Key Players..................................................................... 119
Table 8.7: Market Dynamics (Airless Dispensers and Bottles)........................................................ 130
Table 8.8: Key Product Specifications (Airless Dispensers and Bottles) ........................................ 131
Table 8.9: Unit Volume Sold (Airless Dispensers and Bottles) – Key Players ................................ 133
Table 8.10: Market Dynamics (Dermal Pumps) ............................................................................... 137
Table 8.11: Key Product Specifications (Dermal Pumps) ................................................................ 137
Table 8.12: Unit Volume Sold (Dermal Pumps) – Key Players ....................................................... 139
Table 8.13: Market Dynamics (Valves)............................................................................................. 143

Table 8.14: Key Product Specifications (Valves) ............................................................................. 144

Table 8.15: Unit Volume Sold (Valves) – Key Players ..................................................................... 145
Table 8.16: Market Dynamics (Other Devices) ................................................................................ 149
Table 8.17: Key Product Specifications (Other Devices) ................................................................. 150
Table 8.18: Unit Volume Sold (Other Devices) – Key Players ........................................................ 151
Table 8.19: Market Dynamics (Packaging Products) ....................................................................... 154
Table 11.1: North America Advanced Dermatology Drug Delivery Devices Market Dynamics
Impact Analysis ..................................................................................................................... 169
Table 11.2: Europe Advanced Dermatology Drug Delivery Devices Market Dynamics Impact
Analysis ................................................................................................................................. 176
Table 11.3: Asia-Pacific Advanced Dermatology Drug Delivery Devices Market Dynamics
Impact Analysis ..................................................................................................................... 189
Table 11.4: Latin America Advanced Dermatology Drug Delivery Devices Market Dynamics
Impact Analysis ..................................................................................................................... 200
Table 11.5: Rest-of-the-World Advanced Dermatology Drug Delivery Devices Market
Dynamics Impact Analysis .................................................................................................... 209

List of Figures
Figure 1: Global Advanced Dermatology Drug Delivery Devices Market Dynamics Impact
Analysis ................................................................................................................................... 30
Figure 2: Potential COVID-19 Recovery Scenarios of Global Advanced Dermatology Drug
Delivery Devices Market ......................................................................................................... 33
Figure 2.1: Global Advanced Dermatology Drug Delivery Devices Market Segmentation .............. 38
Figure 3.1: Global Advanced Dermatology Drug Delivery Devices Market, Research
Methodology ............................................................................................................................ 41
Figure 3.2: Primary Research ............................................................................................................. 43
Figure 3.3: Secondary Research ........................................................................................................ 43
Figure 3.4: Data Triangulation............................................................................................................. 45
Figure 3.5: Global Advanced Dermatology Drug Delivery Devices Market Research Process ....... 46
Figure 3.6: Assumptions and Limitations............................................................................................ 47
Figure 4.1: Global Advanced Dermatology Drug Delivery Devices Market: Key Trends ................. 50
Figure 4.2: Global Advanced Dermatology Drug Delivery Devices Market Key Trends,
Short-Term Impact Analysis, 2023-2025 ............................................................................... 51
Figure 4.3: Global Advanced Dermatology Drug Delivery Devices Market, Key Trends,
Mid-Term Impact Analysis, 2026-2031 .................................................................................. 52
Figure 4.4: Global Advanced Dermatology Drug Delivery Devices Market Key Trends,
Long-Term Impact Analysis, 2029-2033 ................................................................................ 53
Figure 4.5: Global Advanced Dermatology Drug Delivery Device Supply Chain ............................. 54
Figure 4.6: Global Advanced Dermatology Drug Delivery Devices Market Funding Analysis,
$Million, January 2017-January 2021 .................................................................................... 57
Figure 4.7: Global Advanced Dermatology Drug Delivery Devices Market, Patent Analysis (by
Country), January 2018-June 2021 ........................................................................................ 65
Figure 4.8: Global Advanced Dermatology Drug Delivery Devices Market, Patent Analysis (by
Year), 2018-2021 .................................................................................................................... 66
Figure 5.1: Key Impact of COVID-19 on Global Advanced Dermatology Drug Delivery Devices
Market...................................................................................................................................... 68
Figure 5.2: COVID-19 Impact on the Supply Chain of Global Advanced Dermatology Drug
Delivery Market ....................................................................................................................... 69

Figure 5.3: COVID-19 Impact Analysis on Global Advanced Dermatology Drug Delivery Devices
Adoption .................................................................................................................................. 70
Figure 6.1: Global Advanced Dermatology Drug Delivery Market, Company Revenue Share
Analysis, $Million, 2020 .......................................................................................................... 74
Figure 6.2: Share of Key Developments and Strategies in the Global Advanced Dermatology
Drug Delivery Devices Market (by Category), January 2017- June 2021 ............................ 76
Figure 6.3: Global Advanced Dermatology Drug Delivery Devices Market Key Developments,
January 2017-June 2021 ........................................................................................................ 77
Figure 6.4: Global Advanced Dermatology Drug Delivery Devices Market Funding Activities (by
Company), January 2017-June 2021 ..................................................................................... 78
Figure 6.5: Global Advanced Dermatology Drug Delivery Devices Market Mergers and
Acquisitions (by Company), January 2017-June 2021 .......................................................... 79
Figure 6.6: Global Advanced Dermatology Drug Delivery Devices Market Partnerships,
Alliances, and Business Expansions (by Company), January 2017-June 2021 .................. 80
Figure 6.7: Global Advanced Dermatology Drug Delivery Devices Market Regulatory and Legal
Activities (by Company), January 2017-June 2021 ............................................................... 81
Figure 6.8: Global Advanced Dermatology Drug Delivery Devices Market New Offerings (by
Company), January 2017-June 2021 ..................................................................................... 82
Figure 7.1: Global Advanced Dermatology Drug Delivery Devices Market Incremental
Opportunity, $Million, 2020-2030 ........................................................................................... 87
Figure 7.2: Global Advanced Dermatology Drug Delivery Devices Market, Potential Forecast
Scenarios ................................................................................................................................ 88
Figure 7.3: Global Advanced Dermatology Drug Delivery Devices Market Size and Growth
Potential (Realistic Scenario), $Million, 2019-2030 ............................................................... 89
Potential (Pessimistic Scenario), $Million, 2019-2030........................................................... 90
Potential (Optimistic Scenario), $Million, 2019-2030 ............................................................. 91
Figure 7.6: Global Advanced Dermatology Drug Delivery Devices Market Dynamics Impact
Analysis ................................................................................................................................... 92
Figure 7.7: Global Advanced Dermatology Drug Delivery Devices Market, Connected
Ecosystem ............................................................................................................................... 93

Figure 7.8: Global Advanced Dermatology Drug Delivery Devices Market, Medication
Adherence Growth Benefits.................................................................................................... 97
Figure 8.1: Global Advanced Dermatology Drug Delivery Devices Market (by Product Type) ...... 101
Figure 8.2: Global Advanced Dermatology Drug Delivery Devices Market Growth Share
Matrix (by Product Type), 2020-2030................................................................................... 102
Figure 8.3: Global Advanced Dermatology Drug Delivery Devices Market (Hardware),
$Million, 2019-2030............................................................................................................... 103
Figure 8.4: Global Advanced Dermatology Drug Delivery Devices Market Key Players
Competitive Benchmarking (Injectors) ................................................................................. 104
Figure 8.5: Injectors Market Volume Analysis, Million Unit, 2019-2030 .......................................... 108
Figure 8.6: Injectors Market Volume Analysis (by End Market), Million Unit, 2019-2030 ............... 110
Figure 8.7: Global Advanced Dermatology Drug Delivery Devices Market (Injectors), $Million,
2019-2030 ............................................................................................................................. 111
Figure 8.8: Global Advanced Dermatology Drug Delivery Devices Market (Disposable Injectors),
$Million, 2019-2030............................................................................................................... 112
Figure 8.9: Global Advanced Dermatology Drug Delivery Devices Market (Reusable Injectors),
$Million, 2019-2030............................................................................................................... 113
Figure 8.10: Global Advanced Dermatology Drug Delivery Devices Market (Wearable Injectors),
$Million, 2019-2030............................................................................................................... 114
Competitive Benchmarking (Patches) .................................................................................. 115
Figure 8.12: Patches Market Volume Analysis, Million Unit, 2019-2030......................................... 118
Figure 8.13: Patches Market Volume Analysis (by End Market), Million Unit, 2020 ....................... 119
Figure 8.14: Global Advanced Dermatology Drug Delivery Devices Market (Patches), $Million,
2019-2030 ............................................................................................................................. 120
Figure 8.15: Global Advanced Dermatology Drug Delivery Devices Market (Microneedle
Patches), $Million, 2019-2030 .............................................................................................. 122
Figure 8.16: Global Advanced Dermatology Drug Delivery Devices Market (Solid Removable
Microneedles), $Million, 2019-2030 ..................................................................................... 123
Figure 8.17: Global Advanced Dermatology Drug Delivery Devices Market (Coated

Figure 8.18: Global Advanced Dermatology Drug Delivery Devices Market (Dissolving
Figure 8.19: Global Advanced Dermatology Drug Delivery Devices Market (Hollow
Figure 8.20: Global Advanced Dermatology Drug Delivery Devices Market (Hydrogel Forming
Figure 8.21: Global Advanced Dermatology Drug Delivery Devices Market (Needle-Less
Patches), $Million, 2019-2030 .............................................................................................. 128
Competitive Benchmarking (Airless Dispensers and Bottles) ............................................. 129
Figure 8.23: Airless Dispensers and Bottles Market Volume Analysis, Million Unit, 2019-2030 .... 132
Figure 8.24: Airless Dispensers and Bottles Market Volume Analysis (by End Market),
Million Unit, 2020................................................................................................................... 134
Figure 8.25: Global Advanced Dermatology Drug Delivery Devices Market (Airless
Dispensers and Bottles), $Million, 2019-2030 ..................................................................... 135
Competitive Benchmarking (Dermal Pumps)....................................................................... 136
Figure 8.27: Dermal Pumps Market Volume Analysis, Million Unit, 2019-2030 ............................. 139
Figure 8.28: Dermal Pumps Market Volume Analysis (by End Market), Million Unit, 2020 ........... 140
Figure 8.29: Global Advanced Dermatology Drug Delivery Devices Market (Dermal Pumps),
$Million, 2019-2030............................................................................................................... 141
Competitive Benchmarking (Valves) .................................................................................... 142
Figure 8.31: Valves Market Volume Analysis, Million Unit, 2019-2030 ........................................... 145
Figure 8.32: Valves Market Volume Analysis (by End Market), Million Unit, 2020 ......................... 146
Figure 8.33: Global Advanced Dermatology Drug Delivery Devices Market (Valves), $Million,
2019-2030 ............................................................................................................................. 147
Competitive Benchmarking (Other Devices) ........................................................................ 148
Figure 8.35: Other Devices Market Volume Analysis, Million Unit, 2019-2030............................... 151
Figure 8.36: Other Devices Market Volume Analysis (by End Market), Million Unit, 2020............. 152

Figure 8.37: Global Advanced Dermatology Drug Delivery Devices Market (Other Devices),
$Million, 2019-2030............................................................................................................... 153
Figure 8.38: Global Advanced Dermatology Drug Delivery Devices Market (Packaging Products),
$Million, 2019-2030............................................................................................................... 155
Figure 8.39: Global Advanced Dermatology Drug Delivery Devices Market (Software and Apps),
$Million, 2019-2030............................................................................................................... 156
Figure 9.1: Global Advanced Dermatology Drug Delivery Devices Market (by Sales Channel) .... 157
Opportunity (by Sales Channel), $Million, 2020-2030 ......................................................... 158
Figure 9.3: Global Advanced Dermatology Drug Delivery Devices Market (B2B Sales Channel),
$Million, 2019-2030............................................................................................................... 159
Figure 9.4: Global Advanced Dermatology Drug Delivery Devices Market (B2C Sales Channel),
$Million, 2019-2030............................................................................................................... 160
Figure 10.1: Global Advanced Dermatology Drug Delivery Devices Market (by End User) .......... 161
Opportunity (by End User), $Million, 2020-2030.................................................................. 162
Figure 10.3: Global Advanced Dermatology Drug Delivery Devices Market (Hospitals),
$Million, 2019-2030............................................................................................................... 163
Figure 10.4: Global Advanced Dermatology Drug Delivery Devices Market (Dermatology
Practices), $Million, 2019-2030 ............................................................................................ 164
Figure 10.5: Global Advanced Dermatology Drug Delivery Devices Market (Home Use),
$Million, 2019-2030............................................................................................................... 165
Figure 11.1: Global Advanced Dermatology Drug Delivery Devices Market Share
(by Region), 2020-2030 ........................................................................................................ 166
Figure 11.2: North America Advanced Dermatology Market Incremental Revenue
Opportunity (by Country), $Million, 2020-2030 .................................................................... 167
Figure 11.3: North America Advanced Dermatology Drug Delivery Devices Market,
$Million, 2019-2030............................................................................................................... 170
Figure 11.4: North America Advanced Dermatology Drug Delivery Devices Market (by
Product Type), $Million, 2019-2030 ..................................................................................... 171
Figure 11.5: North America Advanced Dermatology Drug Delivery Devices Market (by
End User), $Million, 2019-2030 ............................................................................................ 172

Figure 11.6: U.S. Advanced Dermatology Drug Delivery Devices Market, $Million,
2019-2030 ............................................................................................................................. 173
Figure 11.7: Canada Advanced Dermatology Drug Delivery Devices Market, $Million,
2019-2030 ............................................................................................................................. 174
Figure 11.8: Europe Advanced Dermatology Drug Delivery Devices Market Incremental
Figure 11.9: Europe Advanced Dermatology Drug Delivery Devices Market, $Million,
2019-2030 ............................................................................................................................. 177
Figure 11.10: Europe Advanced Dermatology Drug Delivery Devices Market (by Product Type),
$Million, 2019-2030............................................................................................................... 178
Figure 11.11: Europe Advanced Dermatology Drug Delivery Devices Market (by End User),
$Million, 2019-2030............................................................................................................... 180
Figure 11.12: Germany Advanced Dermatology Drug Delivery Devices Market, $Million,
2019-2030 ............................................................................................................................. 181
Figure 11.13: U.K. Advanced Dermatology Drug Delivery Devices Market, $Million,
2019-2030 ............................................................................................................................. 182
Figure 11.14: France Advanced Dermatology Drug Delivery Devices Market, $Million,
2019-2030 ............................................................................................................................. 183
Figure 11.15: Italy Advanced Dermatology Drug Delivery Devices Market, $Million,
2019-2030 ............................................................................................................................. 184
Figure 11.16: Spain Advanced Dermatology Drug Delivery Devices Market, $Million,
2019-2030 ............................................................................................................................. 185
Figure 11.17: Nordic Countries Advanced Dermatology Drug Delivery Devices Market, $Million,
2019-2030 ............................................................................................................................. 186
Figure 11.18: Rest-of-Europe Advanced Dermatology Drug Delivery Devices Market, $Million,
2019-2030 ............................................................................................................................. 187
Figure 11.19: Asia-Pacific Advanced Dermatology Drug Delivery Devices Market Incremental
Figure 11.20: Asia-Pacific Advanced Dermatology Drug Delivery Devices Market, $Million,
2019-2030 ............................................................................................................................. 190
Figure 11.21: Asia-Pacific Advanced Dermatology Drug Delivery Devices Market (by Product
Type), $Million, 2019-2030 ................................................................................................... 191

Figure 11.22: Asia-Pacific Advanced Dermatology Drug Delivery Devices Market (by End User),
$Million, 2019-2030............................................................................................................... 192
Figure 11.23: Japan Advanced Dermatology Drug Delivery Devices Market, $Million,
2019-2030 ............................................................................................................................. 193
Figure 11.24: China Advanced Dermatology Drug Delivery Devices Market, $Million,
2019- 2030 ............................................................................................................................ 194
Figure 11.25: South Korea Advanced Dermatology Drug Delivery Devices Market, $Million,
2019-2030 ............................................................................................................................. 195
Figure 11.26: Australia and New Zealand Advanced Dermatology Drug Delivery Devices
Market, $Million, 2019-2030 ................................................................................................. 196
Figure 11.27: India Advanced Dermatology Drug Delivery Devices Market, $Million,
2019-2030 ............................................................................................................................. 197
Figure 11.28: Rest-of-Asia-Pacific Advanced Dermatology Drug Delivery Devices Market,
$Million, 2019-2030............................................................................................................... 198
Figure 11.29: Latin America Advanced Dermatology Drug Delivery Devices Market Incremental
Figure 11.30: Latin America Advanced Dermatology Drug Delivery Devices Market, $Million,
2019-2030 ............................................................................................................................. 201
Figure 11.31: Latin America Advanced Dermatology Drug Delivery Devices Market (by Product
Type), $Million, 2019-2030 ................................................................................................... 202
Figure 11.32: Latin America Advanced Dermatology Drug Delivery Devices Market (by
End User), $Million, 2019-2030 ............................................................................................ 203
Figure 11.33: Brazil Advanced Dermatology Drug Delivery Devices Market, $Million,
2019-2030 ............................................................................................................................. 204
Figure 11.34: Mexico Advanced Dermatology Drug Delivery Devices Market, $Million,
2019-2030 ............................................................................................................................. 205
Figure 11.35: Argentina Advanced Dermatology Drug Delivery Devices Market, $Million,
2019-2030 ............................................................................................................................. 206
Figure 11.36: Rest-of-Latin America Advanced Dermatology Drug Delivery Devices Market,
$Million, 2019-2030............................................................................................................... 207
Figure 11.37: Rest-of-the-World Advanced Dermatology Drug Delivery Devices Market,
$Million, 2019-2030............................................................................................................... 210

Figure 11.38: Rest-of-the-World Advanced Dermatology Drug Delivery Devices Market

(by Product Type), $Million, 2019-2030 ............................................................................... 211
Figure 11.39: Rest-of-the-World Advanced Dermatology Drug Delivery Devices Market (by
End User), $Million, 2019-2030 ............................................................................................ 212
Figure 12.1: AptarGroup, Inc.: Overall Product Portfolio ................................................................. 214
Figure 12.2: AptarGroup, Inc. Volume Analysis (by Airless Dispensers and Bottles), Million
Units, 2020 ............................................................................................................................ 215
Figure 12.3: AptarGroup, Inc.: Overall Financials, 2018-2020 ........................................................ 216
Figure 12.4: AptarGroup, Inc.: Net Revenue (by Segment), $Million, 2018-2020 .......................... 217
Figure 12.5: AptarGroup, Inc.: Net Revenue (by Region), $Million, 2018-2020 ............................. 217
Figure 12.6: AptarGroup, Inc.: R&D Expenditure, 2018-2020 ......................................................... 218
Figure 12.7: AptarGroup, Inc.: SWOT Analysis ............................................................................... 219
Figure 12.8: Becton, Dickinson and Company: Overall Product Portfolio ....................................... 221
Figure 12.9: Becton, Dickinson and Company: Overall Financials, 2018-2020.............................. 221
Figure 12.10: Becton, Dickinson and Company: Net Revenue (by Segment), $Million,
2018-2020 ............................................................................................................................. 222
Figure 12.11: Becton, Dickinson and Company: Net Revenue (by Region), $Million,
2018-2020 ............................................................................................................................. 223
Figure 12.12: Becton, Dickinson and Company: R&D Expenditure, 2018-2020 ............................ 223
Figure 12.13: Becton, Dickinson and Company: SWOT Analysis ................................................... 224
Figure 12.14: Bespak: Overall Product Portfolio .............................................................................. 226
Figure 12.15: Bespak: SWOT Analysis ............................................................................................ 227
Figure 12.16: Credence MedSystems, Inc.: Overall Product Portfolio ............................................ 229
Figure 12.17: Credence MedSystems, Inc.: SWOT Analysis .......................................................... 230
Figure 12.18: E3D Elcam Drug Delivery Devices: Overall Product Portfolio .................................. 232
Figure 12.19: E3D Elcam Drug Delivery Devices: SWOT Analysis ................................................ 233
Figure 12.20: Kindeva Drug Delivery L.P.: Overall Product Portfolio .............................................. 235
Figure 12.21: Kindeva Drug Delivery L.P.: SWOT Analysis ............................................................ 235
Figure 12.22: Latch Medical: Overall Product Portfolio .................................................................... 237
Figure 12.23: Latch Medical: SWOT Analysis .................................................................................. 237
Figure 12.24: LTS Lohmann Therapie-Systeme AG: Overall Product Portfolio ............................. 239
Figure 12.25: LTS Lohmann Therapie-Systeme AG: SWOT Analysis ........................................... 240

Figure 12.26: Medicsensors S.L: Overall Product Portfolio ............................................................. 242

Figure 12.27: Medicsensors S.L: SWOT Analysis ........................................................................... 242
Figure 12.28: Midas Pharma GmbH: Overall Product Portfolio ....................................................... 244
Figure 12.29: Midas Pharma GmbH: SWOT Analysis ..................................................................... 245
Figure 12.30: Nemera: Overall Product Portfolio ............................................................................. 247
Figure 12.31: Nemera: SWOT Analysis ........................................................................................... 248
Figure 12.32: Owen Mumford: Overall Product Portfolio ................................................................. 250
Figure 12.33: Owen Mumford: SWOT Analysis ............................................................................... 251
Figure 12.34: Portal Instruments, Inc.: Overall Product Portfolio..................................................... 253
Figure 12.35: Portal Instruments, Inc.: SWOT Analysis................................................................... 254
Figure 12.36: Vaxxas Inc.: Overall Product Portfolio ....................................................................... 256
Figure 12.37: Vaxxas Inc.: SWOT Analysis ..................................................................................... 257
Figure 12.38: West Pharmaceutical Services, Inc.: Overall Product Portfolio ................................ 259
Figure 12.39: West Pharmaceutical Services, Inc.: Overall Financials, 2018-2020 ....................... 260
Figure 12.40: West Pharmaceutical Services, Inc.: Net Revenue (by Segment), $Million,
2018-2020 ............................................................................................................................. 261
Figure 12.41: West Pharmaceutical Services, Inc.: Net Revenue (by Region), $Million,
2018-2020 ............................................................................................................................. 262
Figure 12.42: West Pharmaceutical Services, Inc.: R&D Expenditure, 2018-2020 ........................ 262
Figure 12.43: West Pharmaceutical Services, Inc.: SWOT Analysis .............................................. 263

BIS Research Offerings:

We are on a mission to harness the potential of disruptive technologies to make businesses thrive in
today’s digital age. We have a vision to be a leading and a preferred knowledge partner for corporates
and institutions worldwide and assist them with market intelligence in the area of emerging
technologies, advisories, and other innovative solutions.
Know More Know More Know More
Know More

Disclaimer
BIS Research provides valuable market intelligence to an exclusive group of customers in response
to orders. The report is licensed for the customer's internal use only and is subject to restrictions set
henceforth. This document and its contents are confidential and may not be further distributed,
published, or reproduced, in whole or in part, by any medium or in any form for any purpose, without
the express written consent of BIS Research. Customer will not disclose the contents of the report,
whether directly in any media or indirectly through incorporation in a database, marketing list, report,
or otherwise or use or permit the use of information to generate any statistical or other information
that is or will be provided to third parties; or voluntarily produce information in legal proceedings.
Market reports are based on expectations, estimates, and projections as of the date such information
is available. Any recommendation contained in this report may not be suitable for all investors or
businesses. The market conclusions drawn are necessarily based upon a number of estimates and
assumptions that, while considered reasonable by BIS Research as of the date of such statements,
are inherently subject to market fluctuations and business, economic and competitive uncertainties
and contingencies.
For more details regarding permission, please contact us:

Email: sales@bisresearch.com
Tel: +1 510 404 8135

BIS RESEARCH INC.
39111 Paseo Padre PKWY, Suite 313 Fremont, CA 94538 -1686
E-mail: info@bisresearch.com | Call Us: +1-510-404-8135
Global Delivery Center
Tower B First Floor, Tapasya Corporate Heights, Greater Noida Expressway,
Sector 126, Noida, U.P., 201303, India
Tel: +91 120 4261540 / 4261544
www.bisresearch.com

Global Advanced Dermatology Drug Delivery Devices Market

Uploaded by

Copyright:

Available Formats

Global Advanced Dermatology Drug Delivery Devices Market

Uploaded by

Document Information

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

Global Advanced Dermatology Drug Delivery Devices Market

Uploaded by

Copyright:

Available Formats

F u-=

Copyright © 2021 BIS Research

All rights reserved at BIS Research 2

1. Product Definition ..............................................................................................36

2. Scope of Research .............................................................................................37

3. Research Methodology ......................................................................................41

All rights reserved at BIS Research 3

4.4.3 Regulations in Asia-Pacific .............................................................. 63

5. Impact of COVID-19 on Global Advanced Dermatology Drug Delivery

6. Competitive Landscape .....................................................................................74

7. Global Advanced Dermatology Drug Delivery Devices Market Scenario ......85

All rights reserved at BIS Research 4

7.3 Global Advanced Dermatology Drug Delivery Devices Market Size

8. Global Advanced Dermatology Drug Delivery Devices Market (by

All rights reserved at BIS Research 5

8.3.1.4.1 Key Players ......................................................................... 109

All rights reserved at BIS Research 6

8.3.4.3 Key Product Specifications ............................................................ 137

9. Global Advanced Dermatology Drug Delivery Devices Market (by Sales

All rights reserved at BIS Research 7

10. Global Advanced Dermatology Drug Delivery Devices Market (by

11. Global Advanced Dermatology Drug Delivery Devices Market

All rights reserved at BIS Research 8

11.3.6.2 U.K. ................................................................................................ 181

All rights reserved at BIS Research 9

11.5.6.2 Mexico ........................................................................................... 205

12. Company Profiles .............................................................................................213

All rights reserved at BIS Research 10

12.2.5 SWOT Analysis ................................................................................ 224

All rights reserved at BIS Research 11

12.8.2 Role of LTS Lohmann Therapie-Systeme AG in the Global

All rights reserved at BIS Research 12

12.14 Vaxxas Inc................................................................................................... 255

All rights reserved at BIS Research 13

All rights reserved at BIS Research 14

Table 8.14: Key Product Specifications (Valves) ............................................................................. 144

All rights reserved at BIS Research 15

All rights reserved at BIS Research 16

All rights reserved at BIS Research 17

All rights reserved at BIS Research 18

All rights reserved at BIS Research 19

All rights reserved at BIS Research 20

All rights reserved at BIS Research 21

All rights reserved at BIS Research 22

Figure 11.38: Rest-of-the-World Advanced Dermatology Drug Delivery Devices Market

All rights reserved at BIS Research 23

Figure 12.26: Medicsensors S.L: Overall Product Portfolio ............................................................. 242

All rights reserved at BIS Research 24

BIS Research Offerings:

Know More Know More Know More

All rights reserved at BIS Research 25

For more details regarding permission, please contact us:

All rights reserved at BIS Research 26

BIS RESEARCH INC.

39111 Paseo Padre PKWY, Suite 313 Fremont, CA 94538 -1686

E-mail: info@bisresearch.com | Call Us: +1-510-404-8135

Global Delivery Center

Tower B First Floor, Tapasya Corporate Heights, Greater Noida Expressway,

Sector 126, Noida, U.P., 201303, India

Tel: +91 120 4261540 / 4261544